Flu Vaccines
VaxInnates Second Flu Vaccine Candidate Enters Clinical Development; Results Expected in Early 2009
Published in Vaccine Weekly, October 22nd, 2008
The Phase I study is expected to yield important information about the safety and immunogenicity – or ability to generate an immune response -- of VaxInnate's hemagglutinin (HA)-flagellin flu vaccine candidate. The study is taking place at the University of Rochester in New York. Results are expected in early 2009.
The HA vaccine candidate links the hemagglutinin (HA) antigen, which has been the key protective component in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-10-22)
More Articles from Vaccine Weekly
- Children's Hospital Boston
New insights could lead to a better pneumococcal vaccine - Children's National Medical Center
Children's National researchers develop novel anti-tumor vaccine - Emory University
Scientists find new insight into genome of neglected malaria parasite - NIH/National Institute of Allergy and Infectious Diseases
Scientists decode genome of parasite that causes relapsing malaria - University of Leicester
New study determines double flu jab needed against bird flu pandemic - DNA Research
Researchers at University of Athens release new data on DNA research - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
